Ethics and Malpractice Statement

Ethics and Malpractice Statement

The Journal of Stem Cell Therapy and Transplantation (JSCTT) upholds the highest standards of ethical publishing, ensuring that research integrity, transparency, and accountability are maintained throughout the publication process. We adhere to the ethical guidelines established by the Committee on Publication Ethics (COPE) and follow international best practices outlined by the International Committee of Medical Journal Editors (ICMJE).

Editorial Responsibilities

The editorial team of JSCTT is committed to ensuring a fair and unbiased review process. Editors are responsible for:

  • Overseeing a thorough and transparent peer-review process.
  • Making editorial decisions based on scientific merit and research quality.
  • Maintaining the confidentiality of submitted manuscripts.
  • Identifying and addressing any ethical breaches, including plagiarism and data manipulation.
  • Following COPE guidelines when handling corrections, retractions, or ethical disputes.

Author Responsibilities

Authors submitting to JSCTT are expected to adhere to the highest ethical standards, including:

  • Submitting original, previously unpublished work.
  • Avoiding plagiarism, fabrication, or falsification of data.
  • Properly acknowledging sources and providing accurate citations.
  • Disclosing any conflicts of interest or funding sources.
  • Ensuring all listed authors have made significant contributions to the research.
  • Complying with ethical guidelines for stem cell research, including obtaining proper regulatory approvals.

Reviewer Responsibilities

Peer reviewers play a crucial role in maintaining the quality of published research. Reviewers for JSCTT must:

  • Provide constructive, objective, and unbiased feedback.
  • Maintain confidentiality regarding manuscript content.
  • Report any ethical concerns, such as suspected plagiarism or conflicts of interest.
  • Refrain from using unpublished research data for personal gain.
  • Assess research rigor, particularly in compliance with ethical guidelines for stem cell studies.

Plagiarism and Research Misconduct

JSCTT enforces strict policies against research misconduct, including:

  • Plagiarism: Manuscripts undergo plagiarism screening before review.
  • Data Manipulation: Falsification or alteration of data is strictly prohibited.
  • Duplicate Submission: Research should not be under review in multiple journals simultaneously.
  • Improper Authorship: All co-authors must have made a genuine contribution to the work.

Handling Ethical Violations

In cases of ethical violations, JSCTT follows a structured investigation process:

  • Initial Review: Allegations of misconduct are assessed by the editorial board.
  • Author Notification: Authors are given an opportunity to respond.
  • Corrective Actions: If a violation is confirmed, measures such as rejection, retraction, or institutional reporting may be taken.

Commitment to Ethical Publishing

The Journal of Stem Cell Therapy and Transplantation is dedicated to fostering ethical research and upholding academic integrity. We expect all stakeholders—authors, reviewers, and editors—to adhere to our ethical policies, ensuring the credibility and impact of published research in stem cell therapy.

For ethical concerns or inquiries, please contact the editorial office at [email protected].